SB 589, the “Stop Antiabortion Disinformation Act” or “SAD Act,” would make it unlawful to engage in deceptive advertising about abortion-related reproductive health services. The bill is aimed primarily at crisis pregnancy centers and similar organizations that advertise in ways that suggest they provide abortion or contraception services, referrals for those services, or licensed medical personnel when they do not. It also targets misleading claims about privacy practices, including false assertions of HIPAA compliance, and is framed as a consumer-protection measure to ensure people seeking reproductive health care receive accurate information.
The bill directs the Federal Trade Commission to enforce these prohibitions under the Federal Trade Commission Act framework. It authorizes the FTC to issue regulations, investigate violations, seek injunctions and civil penalties, and obtain restitution or other relief for harmed consumers. The bill also applies the FTC’s enforcement authority to nonprofit organizations, sets a civil penalty of up to $100,000 per violation or 50% of the ultimate parent entity’s prior-year revenue, and requires the FTC to report to Congress every two years on enforcement actions and regulations. The bill defines “abortion services” broadly to include abortion itself and related medical or non-medical services.
In terms of state-law impact, the bill is federal and would not directly amend state statutes, but it would create a nationwide federal prohibition on deceptive abortion-related advertising that could affect organizations operating in every state. It would likely preempt or supplement state consumer-protection and false-advertising enforcement where abortion-related advertising is concerned, and it would give the FTC a specific federal tool to police claims made by crisis pregnancy centers and other providers. The practical effect would be to increase legal exposure for entities that market themselves as abortion or contraception providers without actually offering those services.
The overall sentiment reflected in the bill text is strongly supportive of abortion access and strongly critical of antiabortion misinformation. The findings section portrays abortion as essential health care and describes post-Dobbs access barriers, travel burdens, and disproportionate impacts on low-income people and communities of color. Because there are no committee transcripts or recorded votes provided, there is no documented legislative debate or vote history to indicate broader bipartisan support or opposition at this stage; the bill appears to have been introduced and referred to committee only.
The main point of contention is likely to be whether the bill is a necessary consumer-protection measure or an overreach into speech and nonprofit advocacy. Supporters would view it as preventing deceptive advertising and protecting patients from delay and harm, while opponents may argue that it targets crisis pregnancy centers, burdens religious or pro-life organizations, and raises First Amendment concerns about compelled or restricted messaging. The bill’s explicit inclusion of nonprofits under FTC enforcement and its broad definition of abortion-related services are likely to be central issues in any future debate.
SB 589 would create a new federal prohibition on deceptive advertising related to abortion services and would empower the Federal Trade Commission to enforce it as an unfair or deceptive practice under the FTC Act. It would apply to both for-profit and nonprofit entities, authorize rulemaking, civil enforcement, penalties, and consumer relief, and require periodic reporting to Congress. Although it does not directly amend state law, it would establish a nationwide federal standard affecting crisis pregnancy centers, abortion-related advertisers, and other reproductive-health organizations across states.
The bill is presented in strongly pro-abortion-access and anti-disinformation terms. Its findings emphasize the harms of post-Dobbs abortion restrictions, the burden on patients, and the alleged deceptive practices of crisis pregnancy centers. No committee discussion or vote record is provided, so there is no evidence of recorded bipartisan support or opposition in the materials supplied; the bill is simply introduced and referred to committee.
The likely controversy centers on whether the bill is a legitimate consumer-protection measure or an infringement on speech and advocacy by antiabortion and religious nonprofits. Supporters are likely to argue that it prevents misleading advertising, protects patients from delay, and addresses false claims about services and privacy. Opponents are likely to argue that it singles out crisis pregnancy centers, could chill pro-life counseling, and may raise First Amendment and nonprofit-regulation concerns, especially because the FTC is given broad enforcement authority over nonprofits.